The technology, called optogenetics, uses light-sensitive proteins to activate or silence selected neurons. Explaining its significance, Dr Manjari Tripathi, head of neurology at AIIMS, said the approach was particularly promising for refractory epilepsy, where seizures continue despite medicines.
News
Nobel light breakthrough may help switch off seizure-causing brain cells
October 8, 2026The technology, called optogenetics, uses light-sensitive proteins to activate or silence selected neurons. Explaining its significance, Dr Manjari Tripathi, head of neurology at AIIMS, said the approach was particularly promising for refractory epilepsy, where seizures continue despite medicines.